Related Experiment Video
Updated: Oct 17, 2025

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
Published on: October 6, 2015
Negative Impact Factors in HIV-Tuberculosis
Ana-Maria Zaharie1, Mirela Tigau1
1Marius Nasta Institute of Pneumology, 4th District TB Unit, Bucharest, Romania.
Abstract:
About one quarter of all tuberculosis (TB) deaths are among people living with HIV. Tuberculosis is a leading infectious cause of death among persons infected with HIV and the outcome of TB treatment is poorer in these patients. Objective: To identify the factors associated with a poor tuberculosis outcome in patients with HIV-TB coinfection. Material and methods: This is a retrospective cohort study using data from the local TB registry for 2009-2016. We performed descriptive statistics as well as univariate and multivariate analysis. Results: During the study period we identified 86 patients (4.76% of all patients registered for TB treatment) with HIV-TB who had a mean age of 35.05±9.10 years and were mostly male (73.25%). More than half of patients were current drug users (51.16%) and 22.10% homeless. The mean CD4 value was 179.11±204.76/mm3 and 69.76% of patients received antiretroviral treatment during TB treatment. Viral hepatitis was present in 61.62% of cases, and 77.9% of patients were new TB cases. Pulmonary TB was noted in 72 cases, with confirmation by culture being obtained in 84.44% of cases. Treatment success was achieved in 63.95% of cases, 22.09% of patients died, 8.13% abandoned treatment, and 5.81% were lost to follow up. Several factors related to poor outcome were identified by univariate analysis, including drug use (OR=3.14, p=0.027), homeless status (OR=3.01, p=0.039) and viral hepatitis (OR=2.93, p=0.045). Multivariate analysis revealed marginal insignificance for homeless status (p=0.06) and drug use (p=0.86). Conclusion: A special attention and dedicated programs should be considered for patients who are intravenous drug users or those without a stable home.
More Related Videos
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
07:39An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
Published on: August 15, 2012
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Sexually Transmitted Infections
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...